Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET Company Participants Juli Miller - Senior Director, IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer John Lunger - Chief Patient Supply Officer Conference Call Participants Marc Frahm - Cowen and Company Tony Butler - ROTH Capital Mohit Bansal - Citigroup Kelsey Goodwin - Guggenheim Securities Nick Abbott - Wells Fargo S ...